##gff-version 3
##sequence-region Q9BX63 1 1249
Q9BX63	UniProtKB	Chain	1	1249	.	.	.	ID=PRO_0000055173;Note=Fanconi anemia group J protein	
Q9BX63	UniProtKB	Domain	11	442	.	.	.	Note=Helicase ATP-binding;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00541	
Q9BX63	UniProtKB	Nucleotide binding	185	192	.	.	.	Note=ATP;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00541	
Q9BX63	UniProtKB	Region	888	1063	.	.	.	Note=Interaction with BRCA1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11301010;Dbxref=PMID:11301010	
Q9BX63	UniProtKB	Motif	158	175	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9BX63	UniProtKB	Motif	393	396	.	.	.	Note=DEAH box	
Q9BX63	UniProtKB	Metal binding	283	283	.	.	.	Note=Iron-sulfur (4Fe-4S);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9BX63	UniProtKB	Metal binding	298	298	.	.	.	Note=Iron-sulfur (4Fe-4S);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9BX63	UniProtKB	Metal binding	310	310	.	.	.	Note=Iron-sulfur (4Fe-4S);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9BX63	UniProtKB	Metal binding	350	350	.	.	.	Note=Iron-sulfur (4Fe-4S);Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q9BX63	UniProtKB	Modified residue	505	505	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9BX63	UniProtKB	Modified residue	927	927	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q9BX63	UniProtKB	Modified residue	930	930	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332;Dbxref=PMID:18669648,PMID:19690332	
Q9BX63	UniProtKB	Modified residue	956	956	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9BX63	UniProtKB	Modified residue	990	990	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:18669648,ECO:0000269|PubMed:14576433;Dbxref=PMID:18669648,PMID:14576433	
Q9BX63	UniProtKB	Modified residue	1004	1004	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q9BX63	UniProtKB	Modified residue	1032	1032	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:23186163	
Q9BX63	UniProtKB	Modified residue	1237	1237	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:20068231;Dbxref=PMID:20068231	
Q9BX63	UniProtKB	Modified residue	1249	1249	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22792074;Dbxref=PMID:22792074	
Q9BX63	UniProtKB	Alternative sequence	969	994	.	.	.	ID=VSP_012540;Note=In isoform 2. NDPVFLEEAGKAEKIVISRSTSPTFN->SMKSSSHLPLIEKSFIIFSEMIFIWV;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9BX63	UniProtKB	Alternative sequence	995	1249	.	.	.	ID=VSP_012541;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9BX63	UniProtKB	Natural variant	47	47	.	.	.	ID=VAR_020896;Note=In BC%3B early onset%3B loss of ATPase and helicase activities. P->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:14983014;Dbxref=dbSNP:rs28903098,PMID:11301010,PMID:14983014	
Q9BX63	UniProtKB	Natural variant	173	173	.	.	.	ID=VAR_020897;Note=R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11920628,ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988345,PMID:11920628,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	193	193	.	.	.	ID=VAR_020898;Note=V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988346,PMID:11301010,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	195	195	.	.	.	ID=VAR_020899;Note=L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988347,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	255	255	.	.	.	ID=VAR_023700;Note=In FANCJ. Q->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16116423;Dbxref=PMID:16116423	
Q9BX63	UniProtKB	Natural variant	264	264	.	.	.	ID=VAR_023701;Note=Rare polymorphism. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16116423;Dbxref=dbSNP:rs28997569,PMID:16116423	
Q9BX63	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_020900;Note=In BC%3B early onset%3B reduces helicase efficiency on longer substrates. M->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:14983014;Dbxref=dbSNP:rs137852985,PMID:11301010,PMID:14983014	
Q9BX63	UniProtKB	Natural variant	349	349	.	.	.	ID=VAR_023702;Note=In FANCJ%3B destabilizes iron-sulfur-binding and abolishes helicase activity. A->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16116424,ECO:0000269|PubMed:20639400;Dbxref=dbSNP:rs149364097,PMID:16116424,PMID:20639400	
Q9BX63	UniProtKB	Natural variant	419	419	.	.	.	ID=VAR_020901;Note=R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs150624408,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	531	531	.	.	.	ID=VAR_020902;Note=F->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988350,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	540	540	.	.	.	ID=VAR_020903;Note=Q->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988349,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	633	633	.	.	.	ID=VAR_052192;Note=I->M;Dbxref=dbSNP:rs28997572	
Q9BX63	UniProtKB	Natural variant	647	647	.	.	.	ID=VAR_023703;Note=In FANCJ%3B associated with C-707. W->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16116423;Dbxref=dbSNP:rs786202760,PMID:16116423	
Q9BX63	UniProtKB	Natural variant	707	707	.	.	.	ID=VAR_023704;Note=In FANCJ%3B associated with C-647. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:16116423;Dbxref=dbSNP:rs764803896,PMID:16116423	
Q9BX63	UniProtKB	Natural variant	832	832	.	.	.	ID=VAR_020904;Note=C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988355,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	919	919	.	.	.	ID=VAR_020905;Note=S->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:11920628,ECO:0000269|PubMed:12565990,ECO:0000269|PubMed:12872252,ECO:0000269|PubMed:14702039,ECO:0000269|PubMed:16153896,ECO:0000269|PubMed:18987736;Dbxref=dbSNP:rs4986764,PMID:11301010,PMID:11920628,PMID:12565990,PMID:12872252,PMID:14702039,PMID:16153896,PMID:18987736	
Q9BX63	UniProtKB	Natural variant	935	935	.	.	.	ID=VAR_020906;Note=V->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12872252;Dbxref=dbSNP:rs4988356,PMID:12872252	
Q9BX63	UniProtKB	Natural variant	1034	1034	.	.	.	ID=VAR_020907;Note=In a patient with ovarian cancer%3B unknown pathological significance. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12565990;Dbxref=dbSNP:rs1199923024,PMID:12565990	
Q9BX63	UniProtKB	Natural variant	1148	1148	.	.	.	ID=VAR_052193;Note=D->E;Dbxref=dbSNP:rs28997573	
Q9BX63	UniProtKB	Mutagenesis	52	52	.	.	.	Note=Disrupts BRCA1-mediated double-strand break repair. Loss of ATPase and DNA helicase activities. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11301010,ECO:0000269|PubMed:14983014,ECO:0000269|PubMed:16116421;Dbxref=PMID:11301010,PMID:14983014,PMID:16116421	
Q9BX63	UniProtKB	Mutagenesis	986	986	.	.	.	Note=Does not affect the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	988	988	.	.	.	Note=Does not affect the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	989	989	.	.	.	Note=Does not affect the interaction with BRCA1. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	990	990	.	.	.	Note=Disrupts the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	991	991	.	.	.	Note=Abolishes phosphorylation of S-990. Impairs the interaction with BRCA1. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	992	992	.	.	.	Note=Does not affect the interaction with BRCA1. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	993	993	.	.	.	Note=Abolishes phosphorylation of S-990. Impairs the interaction with BRCA1. F->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	997	997	.	.	.	Note=Does not affect the interaction with BRCA1. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	1001	1001	.	.	.	Note=Does not affect the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	1003	1003	.	.	.	Note=Does not affect the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	1004	1004	.	.	.	Note=Does not affect the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	1007	1007	.	.	.	Note=Does not affect the interaction with BRCA1. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	1011	1011	.	.	.	Note=Does not affect the interaction with BRCA1. Y->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Mutagenesis	1013	1013	.	.	.	Note=Does not affect the interaction with BRCA1. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14576433;Dbxref=PMID:14576433	
Q9BX63	UniProtKB	Sequence conflict	641	641	.	.	.	Note=I->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9BX63	UniProtKB	Sequence conflict	767	767	.	.	.	Note=E->I;Ontology_term=ECO:0000305;evidence=ECO:0000305	
